SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer

• Natalie S. Lui,

  Affiliation Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Yi-Wei Yang,

  Affiliation Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Annemieke van Zante,

  Affiliation Department of Pathology, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Petra Buchanan,

  Affiliation Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• David M. Jablons,

  Affiliation Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Hassan Lemjabbar-Alaoui

  * E-mail: hassan.lemjabbar-alaoui@ucsf.edu

  Affiliation Thoracic Oncology Program, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯